These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 10949981

  • 21. Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.
    Yoo BK, Triller DM, Yong CS, Lodise TP.
    Ann Pharmacother; 2004; 38(7-8):1226-35. PubMed ID: 15187209
    [Abstract] [Full Text] [Related]

  • 22. Cost-effectiveness of gemifloxacin: results from the GLOBE study.
    Halpern MT, Palmer CS, Zodet M, Kirsch J.
    Am J Health Syst Pharm; 2002 Jul 15; 59(14):1357-65. PubMed ID: 12132563
    [Abstract] [Full Text] [Related]

  • 23. Performance in practice: bacteriological efficacy in patients with drug-resistant S. pneumoniae.
    Garau J.
    Clin Microbiol Infect; 2004 Apr 15; 10 Suppl 2():28-35. PubMed ID: 14759231
    [Abstract] [Full Text] [Related]

  • 24. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE, Cranfield R, Breisch S, Pettit R.
    J Antimicrob Chemother; 1997 Dec 15; 40 Suppl A():63-72. PubMed ID: 9484875
    [Abstract] [Full Text] [Related]

  • 25. Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.
    Martinez FJ, Grossman RF, Zadeikis N, Fisher AC, Walker K, Ambruzs ME, Tennenberg AM.
    Eur Respir J; 2005 Jun 15; 25(6):1001-10. PubMed ID: 15929954
    [Abstract] [Full Text] [Related]

  • 26. Amoxycillin/clavulanate in acute purulent exacerbations of chronic bronchitis.
    Maesen FP, Davies BI, Baur C.
    J Antimicrob Chemother; 1987 Mar 15; 19(3):373-83. PubMed ID: 3494724
    [Abstract] [Full Text] [Related]

  • 27. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA, Mathew CP, Warner JH, Heyd A, Church D.
    Respir Med; 2000 Nov 15; 94(11):1029-37. PubMed ID: 11127487
    [Abstract] [Full Text] [Related]

  • 28. Comparison of the efficacy and safety of a short course of ceftibuten with that of amoxycillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis.
    Guest N, Langan CE.
    Int J Antimicrob Agents; 1998 Apr 15; 10(1):49-54. PubMed ID: 9624543
    [Abstract] [Full Text] [Related]

  • 29. Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.
    Lode H, File TM, Mandell L, Ball P, Pypstra R, Thomas M, 185 Gemifloxacin Study Group.
    Clin Ther; 2002 Nov 15; 24(11):1915-36. PubMed ID: 12501883
    [Abstract] [Full Text] [Related]

  • 30. Comparative bacteriological efficacy of pharmacokinetically enhanced amoxicillin-clavulanate against Streptococcus pneumoniae with elevated amoxicillin MICs and Haemophilus influenzae.
    Berry V, Hoover J, Singley C, Woodnutt G.
    Antimicrob Agents Chemother; 2005 Mar 15; 49(3):908-15. PubMed ID: 15728883
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin.
    File TM, Schlemmer B, Garau J, Cupo M, Young C, 049 Clinical Study Group.
    J Antimicrob Chemother; 2001 Jul 15; 48(1):67-74. PubMed ID: 11474633
    [Abstract] [Full Text] [Related]

  • 32. Oral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitis.
    Wilson R, Langan C, Ball P, Bateman K, Pypstra R, Gemifloxacin 207 Clinical Study Group.
    Respir Med; 2003 Mar 15; 97(3):242-9. PubMed ID: 12645831
    [Abstract] [Full Text] [Related]

  • 33. Enoxacin in acute exacerbations of chronic bronchitis: a comparison with amoxycillin.
    Prigogine T, Glupczynski Y, Carpiaux JP, Blogie M, Yourassowsky E, Schmerber JS.
    J Antimicrob Chemother; 1988 Feb 15; 21 Suppl B():131-6. PubMed ID: 3129390
    [Abstract] [Full Text] [Related]

  • 34. Comparison of ceftibuten once daily and amoxicillin-clavulanate three times daily in the treatment of acute exacerbations of chronic bronchitis.
    McAdoo MA, Rice K, Gordon GR, Sahn SA.
    Clin Ther; 1998 Feb 15; 20(1):88-100. PubMed ID: 9522107
    [Abstract] [Full Text] [Related]

  • 35. A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis.
    Schaberg T, Ballin I, Huchon G, Bassaris H, Hampel B, Reimnitz P, AECB Study Group.
    J Int Med Res; 2001 Feb 15; 29(4):314-28. PubMed ID: 11675905
    [Abstract] [Full Text] [Related]

  • 36. Discrepancy between antibiotics administered in acute exacerbations of chronic bronchitis and susceptibility of isolated pathogens in respiratory samples: multicentre study in the primary care setting.
    Querol-Ribelles JM, Molina J, Naberan K, Esteban E, Herreras A, Garcia-de-Lomas J.
    Int J Antimicrob Agents; 2006 Nov 15; 28(5):472-6. PubMed ID: 17046209
    [Abstract] [Full Text] [Related]

  • 37. Amoxicillin/clavulanic acid vs cefetamet pivoxil in the treatment of acute exacerbation of chronic bronchitis (AECB) in adults.
    Behler PG, Böge K, Böhning W, Gams W, Gartner-Toth M, Wettengel R.
    J Chemother; 1995 May 15; 7 Suppl 1():16-20. PubMed ID: 8618108
    [Abstract] [Full Text] [Related]

  • 38. A double-blind comparison of low-dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitis.
    Rademaker CM, Sips AP, Beumer HM, Hoepelman IM, Overbeek BP, Möllers MJ, Rozenberg-Arska M, Verhoef J.
    J Antimicrob Chemother; 1990 Nov 15; 26 Suppl D():75-81. PubMed ID: 2286595
    [Abstract] [Full Text] [Related]

  • 39. The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis.
    Read RC, Kuss A, Berrisoul F, Kearsley N, Torres A, Kubin R.
    Respir Med; 1999 Apr 15; 93(4):252-61. PubMed ID: 10464889
    [Abstract] [Full Text] [Related]

  • 40. Cefaclor af versus amoxycillin/clavulanate in acute bacterial exacerbations of chronic bronchitis: a randomised multicentre study.
    Bandak SI, Bolzon LD, Turnak MR, Johns D, Henle SK, Allen BS.
    Int J Clin Pract; 1999 Dec 15; 53(8):578-83. PubMed ID: 10692750
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.